SCHEMBL21749152

SCHEMBL21749152

Cc1nc2cc(-c3ccc(Cl)cc3)nn2c(Cl)c1C(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 11/20 0.59
RAB9A P51151 10/20 0.59
ALDH1A1 P00352 7/20 0.48
DPP4 P27487 4/20 0.48
KMT2A Q03164 2/20 0.48
DPP8 Q6V1X1 2/20 0.48
TP53 P04637 3/20 0.46
KDM4E B2RXH2 6/20 0.44
SMN1; SMN2 Q16637 6/20 0.44
MAPT P10636 4/20 0.43
LMNA P02545 3/20 0.43
CYP2C19 P33261 2/20 0.43
MEN1 O00255 1/20 0.43
HPGD P15428 6/20 0.43
NFKB1 P19838 1/20 0.43
HTT P42858 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
HSD17B10 Q99714 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21749178 0.86 NPC1 (0.57) NPC1RAB9AALDH1A1DPP4KMT2A
SCHEMBL20502590 0.86 NPC1 (0.46) NPC1RAB9AALDH1A1KMT2ATP53
SCHEMBL21749175 0.81 CYP11B2 (0.46) NPC1RAB9AALDH1A1KMT2ATP53
SCHEMBL21775448 0.75 NPC1 (0.55) NPC1RAB9AALDH1A1DPP4KMT2A
SCHEMBL21749166 0.74 DPP4 (0.39) NPC1RAB9AALDH1A1DPP4DPP8
SCHEMBL21775737 0.74 NPC1 (0.62) NPC1RAB9AALDH1A1DPP4KMT2A
SCHEMBL21775456 0.73 NPC1 (0.57) NPC1RAB9AALDH1A1KMT2ATP53
SCHEMBL21775459 0.73 NPC1 (0.53) NPC1RAB9AALDH1A1DPP4KMT2A
SCHEMBL13977780 0.72 NPC1 (0.73) NPC1RAB9AALDH1A1DPP4KMT2A
SCHEMBL21775857 0.72 MAPT (0.57) NPC1RAB9AALDH1A1DPP4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives RICHTER GEDEON NYRT. (HU) 2021-03-30 US disclosed
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives RICHTER GEDEON NYRT. (HU) 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200061068-A1 Pharmacologically Active Aryl-Substituted Pyrazolo[1,5-a]Pyrimidine Derivatives GABRA5, P2RX5, P2RY1 NPC1 1179/4885RAB9A 988/4885ALDH1A1 585/4885
US-10960007-B2 Pharmacologically active aryl-substituted pyrazolo[1,5-a]pyrimidine derivatives GABRA5, P2RX5, P2RY1 NPC1 1179/4885RAB9A 988/4885ALDH1A1 585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.